Knott David M Jr Myriad Genetics Inc Transaction History
Knott David M Jr
- $158 Million
- Q2 2025
A detailed history of Knott David M Jr transactions in Myriad Genetics Inc stock. As of the latest transaction made, Knott David M Jr holds 180,000 shares of MYGN stock, worth $1.16 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
180,000
Previous 160,000
12.5%
Holding current value
$1.16 Million
Previous $1.42 Million
32.7%
% of portfolio
0.61%
Previous 0.89%
Shares
2 transactions
Others Institutions Holding MYGN
# of Institutions
235Shares Held
95.5MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$97.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$59.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$31.8 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$31.1 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$29.6 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $521M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...